For: | Huang JZ, Xia SS, Ye QF, Jiang HY, Chen ZH. Effects of p16 gene on biological behavious in hepatocellular carcimoma cells. World J Gastroenterol 2003; 9(1): 84-88 [PMID: 12508357 DOI: 10.3748/wjg.v9.i1.84] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i1/84.htm |
Number | Citing Articles |
1 |
M. Gabriela Kramer, Ruben Hernandez-Alcoceba, Cheng Qian, Jesus Prieto. Evaluation of hepatocellular carcinoma models for preclinical studies. Drug Discovery Today: Disease Models 2005; 2(1): 41 doi: 10.1016/j.ddmod.2005.05.009
|
2 |
M. C. Moh, T. Zhang, L. H. Lee, S. Shen. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells. Carcinogenesis 2008; 29(12): 2298 doi: 10.1093/carcin/bgn226
|
3 |
Sungkyung Cha, Kyung Lib Jang. Hepatitis B virus X protein stimulates cell growth by downregulating p16 levels via PA28γ-mediated proteasomal degradation.
Journal of General Virology
2020; 101(9): 963 doi: 10.1099/jgv.0.001461
|
4 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_174-1
|
5 |
Snezana Jovanovic-Cupic, Ana Bozovic, Milena Krajnovic, Nina Petrovic. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.76417
|
6 |
Nikola Kokanov, Milena Krajnovic, Snezana Cupic-Jovanovic, Bojana Kozik, Nina Petrovic, Ana Bozovic, Vesna Mandusic. RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin. Archives of Biological Sciences 2022; 74(1): 57 doi: 10.2298/ABS211208004K
|
7 |
Barbara Kramar, Dušan Šuput, Irina Milisav. Differential p16 expression levels in the liver, hepatocytes and hepatocellular cell lines. PeerJ 2021; 9: e12358 doi: 10.7717/peerj.12358
|
8 |
Ja-Lok Ku, Jae-Gahb Park. Biology of SNU Cell Lines. Cancer Research and Treatment 2005; 37(1): 1 doi: 10.4143/crt.2005.37.1.1
|
9 |
Nianxi Zhao, Ge Huang, Liping Guo, Shih-Hsin Lu. ECRG1, a Novel Candidate of Tumor Suppressor Gene in the Esophageal Carcinoma, Triggers a Senescent Program in NIH3T3 Cells. Experimental Biology and Medicine 2006; 231(1): 84 doi: 10.1177/153537020623100110
|
10 |
X Qiu, S Dong, F Qiao, S Lu, Y Song, Y Lao, Y Li, T Zeng, J Hu, L Zhang, L Zhang, H Fan. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 2013; 32(27): 3296 doi: 10.1038/onc.2013.150
|
11 |
Sungkyung Cha, Inbeom Park, Kyung Lib Jang. Hepatitis C virus core protein activates proteasomal activator 28 gamma to downregulate p16 levels via ubiquitin-independent proteasomal degradation. Heliyon 2021; 7(1): e06134 doi: 10.1016/j.heliyon.2021.e06134
|
12 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3173 doi: 10.1007/978-3-319-26956-6_174
|
13 |
Heba Bassiony, Salwa Sabet, Taher A. Salah El-Din, Mona M. Mohamed, Akmal A. El-Ghor, Pranela Rameshwar. Magnetite Nanoparticles Inhibit Tumor Growth and Upregulate the Expression of P53/P16 in Ehrlich Solid Carcinoma Bearing Mice. PLoS ONE 2014; 9(11): e111960 doi: 10.1371/journal.pone.0111960
|
14 |
Sun-Hye Park, Joo Song Lim, Su-Yeon Lim, Indira Tiwari, Kyung Lib Jang. Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation. Cancer Letters 2011; 310(1): 61 doi: 10.1016/j.canlet.2011.06.012
|